Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study. Al Malki MM, Minden MD, Rich ES, Hill JE, et al. Leuk Res 2025;152:107690.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Al Malki MM, Minden MD, Rich ES, Hill JE, et al. Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study. Leuk Res 2025;152:107690.
PMID: 40209615